FMP

FMP

Enter

MTCR - Metacrine, Inc.

Profile of Metacrine, Inc.(MTCR), Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing t

About

ceo

Mr. David M. Maggio

sector

Healthcare

industry

Biotechnology

website

https://www.metacrine.com

exchange

NASDAQ

Description

Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

CIK

0001634379

ISIN

US59101E1038

CUSIP

59101E103

Address

3985 Sorrento Valley Boulevard

Phone

858 369 7800

Country

US

Employee

10

IPO Date

Sep 16, 2020

Key Executives

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep